See All Slides - tctmd.com

Slides

Presentation

The Minimalist Approach to TAVR: Ad Hoc and Single-Staged Procedures

Presenter: Fabian Nietlispach

October 29, 2013

Presentation TCT 2013

TCT-112. Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach

Presenter: William Fearon

October 29, 2013

Presentation TCT 2013

Radial arterial access with ultrasound trial.

Presenter: Arnold Seto

October 29, 2013

Presentation TCT 2013

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Presenter: Koen Keirse

October 29, 2013

Presentation TCT 2013

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Presenter: Gregory Dehmer

October 29, 2013

Presentation

Efficient Evaluation for TAVR: What Do We Really Need?

Presenter: John Webb

October 29, 2013

Presentation TCT 2013

PCI and CABG: Do We Really Need Another Trial?

Presenter: A. Pieter Kappetein

October 29, 2013

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Advertisement

Slides

The Minimalist Approach to TAVR: Ad Hoc and Single-Staged Procedures

TCT-112. Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach

Radial arterial access with ultrasound trial.

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Appropriateness Use Criteria Recommendations for Multivessel and Left Main Disease

Efficient Evaluation for TAVR: What Do We Really Need?

PCI and CABG: Do We Really Need Another Trial?

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content